Koers Advanced Proteome Therapeutics Corp. Toronto S.E.
Aandelen
CA0076281009
Holdingvennootschappen
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 4,65 mln. 6,34 mln. 4,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -1,36 mln. -923K | Nettowinst (verlies) 2022 | - 0 0 | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 324K 441K 299K | Nettoliquiditeiten 2022 | 31,61K 43,11K 29,17K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-4,85
x | K/w-verhouding 2022 |
6,03
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 89,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16-04-18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10-03-09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+66,69% | 5,54 mld. | |
+94,72% | 1,23 mld. | |
+2,57% | 986 mln. | |
+32,46% | 866 mln. | |
+2,39% | 668 mln. | |
-0,36% | 610 mln. | |
-.--% | 600 mln. | |
+10,28% | 536 mln. | |
-.--% | 500 mln. |